Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.85 AUD | +0.71% | -0.35% | -1.72% |
Feb. 27 | Probiotec Limited Declares Interim Dividend, Payable on 15 March 2024 | CI |
Feb. 27 | Probiotec Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Strengths
- Over the last twelve months, the sales forecast has been frequently revised upwards.
Weaknesses
- For the past year, analysts have significantly revised downwards their profit estimates.
Ratings chart - Surperformance
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-1.72% | 150M | - | ||
+26.02% | 661B | C+ | ||
+27.20% | 566B | B | ||
-6.44% | 352B | C+ | ||
+20.57% | 332B | B- | ||
+3.64% | 283B | C+ | ||
+14.32% | 231B | B+ | ||
+5.18% | 200B | B- | ||
-9.00% | 195B | A+ | ||
-4.91% | 145B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- PBP Stock
- Ratings Probiotec Limited